BioAtla
BCAB
76 hedge funds and large institutions have $897M invested in BioAtla in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 8 closing their positions.
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
23% more funds holding
Funds holding: 62 → 76 (+14)
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
0.13% more ownership
Funds ownership: 1.18% → 1.32% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less capital invested
Capital invested by funds: $964M → $897M (-$67.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$38.7M |
| 2 |
PA
Perceptive Advisors
New York
|
+$31M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$21.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$26.7M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$17.4M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$10.9M |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$6.78M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$3.56M |
BCAB Hedge Fund Activity: Q2 2021 in Review
76 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2021, worth a combined $897M — down 7% from $964M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new BCAB positions and 8 closed out — a net gain of 14 holders — while 20 added to existing stakes and 18 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $38.7M. The largest seller was Farallon Capital Management, cutting an estimated $26.7M.
- 76 institutional investors held BioAtla (BCAB) as of Q2 2021, up from 62 in Q1 2021.
- Funds reported $897M of BioAtla stock for Q2 2021, down 7% quarter-over-quarter.
- 22 funds opened new BioAtla positions in Q2 2021 and 8 closed out, a net change of +14 holders.
- The largest BioAtla buyer in Q2 2021 was Wellington Management Group, an estimated $38.7M added.
- The largest BioAtla seller in Q2 2021 was Farallon Capital Management, an estimated $26.7M sold.
Based on aggregated 13F filings for Q2 2021.